Clinical Trial Update: Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing linsitinib and topotecan hydrochloride in patients with relapsed small cell lung cancer. The study is completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Linsitinib (OSI-906) (linsitinib)
• Topotecan hydrochloride (Hycamtin) (topotecan hydrochloride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Small Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-01-14